Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chase Doyle

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Health & Drug Benefits|March 26, 2016
Measuring Value in Healthcare to Improve QualityChase Doyle
American Health & Drug Benefits|March 26, 2016
Nilotinib Yields Better Rates of Molecular Response Than Imatinib in Frontline SettingChase Doyle
American Health & Drug Benefits|September 19, 2015
Immunotherapies Steal the Show at ASCO 2015Chase Doyle
American Health & Drug Benefits|September 19, 2015
Combination Immunotherapy Superior to Monotherapy in Patients with MelanomaChase Doyle
American Health & Drug Benefits|September 19, 2015
CAR-T Cells: The Transplants of the FutureChase Doyle
American Health & Drug Benefits|March 26, 2016
Clinical Pathways and the Oncology Medical Home: First Steps to Value-Based Patient CareChase Doyle
American Health & Drug Benefits|September 19, 2015
Value-Based Healthcare Delivery: The Agenda for OncologyChase Doyle
American Health & Drug Benefits|September 19, 2015
ASCO's Value Initiative: A New Framework Seeking to Standardize Patient-Physician InteractionsChase Doyle
American Health & Drug Benefits|September 19, 2015
Communication Gap with Oncologists, Not Cost, Tops Patients' Value PrioritiesChase Doyle
American Health & Drug Benefits|March 26, 2016
Value-Based Purchasing: Implications for HematologyChase Doyle
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Health & Drug Benefits|March 26, 2016
Measuring Value in Healthcare to Improve QualityChase Doyle
American Health & Drug Benefits|March 26, 2016
Nilotinib Yields Better Rates of Molecular Response Than Imatinib in Frontline SettingChase Doyle
American Health & Drug Benefits|September 19, 2015
Immunotherapies Steal the Show at ASCO 2015Chase Doyle
American Health & Drug Benefits|September 19, 2015
Combination Immunotherapy Superior to Monotherapy in Patients with MelanomaChase Doyle
American Health & Drug Benefits|September 19, 2015
CAR-T Cells: The Transplants of the FutureChase Doyle
American Health & Drug Benefits|March 26, 2016
Clinical Pathways and the Oncology Medical Home: First Steps to Value-Based Patient CareChase Doyle
American Health & Drug Benefits|September 19, 2015
Value-Based Healthcare Delivery: The Agenda for OncologyChase Doyle
American Health & Drug Benefits|September 19, 2015
ASCO's Value Initiative: A New Framework Seeking to Standardize Patient-Physician InteractionsChase Doyle
American Health & Drug Benefits|September 19, 2015
Communication Gap with Oncologists, Not Cost, Tops Patients' Value PrioritiesChase Doyle
American Health & Drug Benefits|March 26, 2016
Value-Based Purchasing: Implications for HematologyChase Doyle
Pageof 2